SL
Shobha Lalasaheb Jadhav
About Shobha Lalasaheb Jadhav
Data last updated:
Shobha Lalasaheb Jadhav is an Additional Director at Kred Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Kred Pharmaceuticals Private Limited reported revenue of ₹1.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kred Pharmaceuticals Private Limited U46497PN2023PTC221892 | Additional Director | 22 Jul 2025 | 2023 | ₹1.2 Lakh (FY 2024) | Active |
Board colleagues of Shobha Lalasaheb Jadhav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lalasaheb Rajaram Jadhav | 11202120 | Kred Pharmaceuticals Private Limited | Additional Director |
| Shailaja Shyamrao Nalawade | 10225279 | Kred Pharmaceuticals Private Limited | Director |
| Shyamrao Uttareshwar Nalawade | 10225278 | Kred Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shobha Lalasaheb Jadhav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shobha Lalasaheb Jadhav
Shobha Lalasaheb Jadhav currently holds 1 directorship: Kred Pharmaceuticals Private Limited (Additional Director, since 22 Jul 2025, revenue ₹1.2 Lakh (FY 2024)).
Shobha Lalasaheb Jadhav was first appointed on 22 Jul 2025 as Additional Director at Kred Pharmaceuticals Private Limited.
The current boards of Shobha Lalasaheb Jadhav's companies include Lalasaheb Rajaram Jadhav (Kred Pharmaceuticals Private Limited), Shailaja Shyamrao Nalawade (Kred Pharmaceuticals Private Limited), Shyamrao Uttareshwar Nalawade (Kred Pharmaceuticals Private Limited).